Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

Annals of Surgical Oncology

Volumn 4, Issue 8, 1997, Pages 628-633

  Pass, Harvey I ^a,c   Temeck, Barbara K ^a   Kranda, Karen ^a   Thomas, Gunther ^a   Russo, Angelo ^a   Smith, Paul ^b   Friauf, Walt ^b   Steinberg, Seth M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Immunochemotherapy; Mesothelioma; Phase III; Photodynamic therapy

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; TAMOXIFEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PEROPERATIVE CARE; PHASE 3 CLINICAL TRIAL; PHOTOCHEMOTHERAPY; PLEURA TUMOR; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERFERON ALFA-2B; INTRAOPERATIVE CARE; MALE; MESOTHELIOMA; MIDDLE AGED; PHOTOCHEMOTHERAPY; PLEURAL NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 0031300337     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303746     Document Type: Article

References (15)

1. Pass HI, Pogrebniak HW. Malignant pleural mesothelioma. Curr Prob Surg October 1993
2. Rusch VW, Saltz L, Venkatraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and system chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994;12:1156-63.
3. Hilaris BS, Nori D, Kwong E, et al. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 1984; 10:352-30.
4. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1996;111:815-25.
5. Sugarbaker DJ, Lynch TJ, Strauss GM, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993;11:1172-8.
6. Takita H, Mang TS, Loewen GM, et al. Surgery and intracavitary photodynamic therapy for malignant pleural mesothelioma. Proceedings of the 5th International PDT Association, 1994:65. Abstract 68.
7. Lofgren L, Larsson M, Thaning L, Hallgren S. Transthoracic endoscopic photodynamic treatment for malignant mesothelioma. Lancet 1991;337:359.
8. Ris HB, Altermatt HJ, Inderbitizi R, et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results. Br J Cancer 1991;64:1116-20.
9. Knight SR, Clarke CP, Daniel FJ, et al. Photodynamic therapy for malignant pleural mesothelioma. Proceedings of the 5th International PDT Association, 1994:66. Abstract 70.
10. Warloe T, Heyerdahl H, Peng Q, et al. Photodynamic therapy of pleural mesothelioma. Proceedings of the 5th International PDT Association, 1994:65. Abstract 69.
11. Pass HI, DeLaney TF, Tochner Z, et al. Intrapleural photodynamic therapy: Results of Phase I Trial. Ann Surg Oncol 1994;1:28-37.
12. Pass HW, Temeck BK, Kranda K, Steinberg SM Pass HI. A Phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction. Ann Surg Oncol 1995;2: 214-20.
13. International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122-8.
14. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966;50: 163-70.